Editor's Review

Given the often large number of drugs taken by a given hepatitis patient, there is a high potential for harmful interactions between these medications and other drugs that may be prescribed for coexisting conditions. This app makes it easy to prevent these problems and ensure patient safety. Simply enter all the drugs prescribed to the patient, and the app will tell you whether each combination of drugs is safe (green light), potentially harmful (yellow light), or outright toxic (red light) - or lets you know if there is no clear data about potential interactions. 

The app works well, costs nothing, and works on phones as well as tablets, Android as well as iOS. For practitioners who treat hepatitis patients, it is clearly worth using.









Healthcare professionals and patients should use this application to search for potential drug-drug interactions between hepatitis drugs and other medications, as recommended by international treatment guidelines. Results are presented as a “Traffic Light” system (red, amber, green) to indicate the recommendation. A brief summary of each interaction is given. The application is available free of charge and has been developed by the Liverpool Drug Interactions Group at the University of Liverpool and Podmedics. This is an “offline” application that is downloaded to your device (~12.2 MB). An internet connection is not required to use the application, but is needed for downloading updates. In hepatitis therapy, patients take more than one hepatitis medication at a time and possibly other drugs to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different hepatitis drugs and other medications that the HCV- and/or HBV-infected patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.hep-druginteractions.org.